Measles cases in the U.S. have hit a new record high in 2026, driven by declining vaccination rates and localized pockets of susceptibility, challenging decades of progress.
A new report identifies marine heatwaves and flood runoff as key triggers for South Australia’s toxic algal bloom, impacting health, tourism, and marine life.
Two best friends discovered they were biological siblings after taking a DNA test, revealing a story of separation at birth and the surprising power of genetic connections.
A massive cyclosporiasis outbreak linked to fresh produce has expanded to four additional states, prompting CDC investigations and warnings about food safety practices.
Growth Asia Summit 2026 brings together healthcare, nutrition, and retail leaders to discuss future food and wellness innovation.
Singapore will host HIMSS APAC Health Conference 2026, bringing together healthcare leaders to discuss digital transformation and medical innovation.
A 33-year-old worker died instantly in Liloan, Cebu, after a massive stack of heavy granite slabs suddenly shifted and collapsed onto him during a routine unloading operation on Wednesday.
The Labor government will extend paid practicums to pharmacy and clinical psychology students. The move aims to support allied health students during unpaid placements, strengthening the future healthcare workforce.
US measles cases have hit a 35-year high due to declining vaccination rates. Public health officials are working to combat misinformation and restore herd immunity to protect communities.
A study finds that 1,700 HIV treatment sites closed following U.S. aid cuts. The disruptions threaten progress in HIV care and highlight the vulnerability of global health programs to political changes.
Health experts advise against avoiding fruits and vegetables despite Cyclospora outbreaks. Proper washing, staying informed about recalls, and cooking can mitigate risks while maintaining a nutritious diet.
A fifth person has died in the Legionnaires’ disease outbreak on New York City’s Upper East Side. Health officials have identified a likely source and are implementing remediation measures to protect public health.
The Ebola outbreak in the Democratic Republic of the Congo has claimed over 1,000 lives. International agencies are responding, but challenges in remote areas and community trust hinder containment efforts.
Prosecutors say high levels of coliform bacteria—linked to faeces—were found in drinking water in Gostivar, after thousands reported poisoning symptoms.
South Korea is expanding access to menstrual products by installing free sanitary-pad dispensers in public facilities, while retailers introduce ultra-cheap “100-won” pads amid concerns over high prices and safety.
A domestic violence suspect was killed in an armed officer-involved shooting on Dusan Street following a high-speed police pursuit in Simi Valley, with neighbors suspecting a mental health crisis.
Oxford Vaccine Group begins a Phase I trial of a Bundibugyo ebolavirus vaccine, administering the experimental dose to the first volunteers in the study.
Volcanic ash fallout from the Fuego Volcano triggered respiratory crises for dozens of residents across Guatemala on July 24, 2026.
Five construction workers sustained injuries on July 24, 2026, when exterior industrial scaffolding collapsed at an urban job site.
Singapore's Ministry of Manpower reported seven work-related traffic deaths on July 24, 2026, triggering urgent safety audits across local industrial sectors.
Over 60 South African birders have joined a surveillance network to monitor avian influenza. Their reports help detect outbreaks early, protecting wildlife and public health.
RNA testing is revealing diverse lung cancer mutations, including gene fusions missed by DNA tests. This advancement allows for more precise, targeted treatments and improves patient outcomes.
Eli Lilly plans to file for approval of a next-generation obesity drug in 2027 after clearing two more trials. The drug aims to improve weight loss outcomes and patient health.
An FDA advisory panel is reviewing restrictions on peptide therapies, weighing patient access against safety concerns. The decision could impact compounding pharmacies and the future of personalized medicine.